Community pharmacy contractors can now access a recording of PSNC’s recent webinar on price concessions.
Around 750 people registered for last week’s webinar which aimed to provide contractors with a better understanding of how the price concession system operates and PSNC’s work in this area. Nine in ten said they would recommend the webinar to others, with 87% saying that they found it useful.
Feedback on the webinar
“Very useful webinar”
“Brilliant, very insightful and would be keen for more webinars like this”
During the webinar, viewers were guided through the price concession process; from applying for a price concession to how prices are finalised and then communicated to pharmacy contractors and their teams. Our in-house experts also explained how price concessions are measured in the Margin Survey and PSNC’s current concerns about how the concessions system is coping.
Medicines pricing and supply issues are putting significantly increased pressure on pharmacy contractors and their teams. This webinar is part of a series of steps we are taking to support contractors at this time.
You can also view the slide pack used: PSNC Price Concessions Webinar 2022
*Please note, to watch the recording you will need to register (or input the email address you registered with previously).
PSNC to seek overhaul of pricing concessions system
News article describing PSNC’s work to escalate concerns about the process for setting price concessions to senior Government officials.
Medicine supply: Contractor Update from PSNC
News article outlining PSNC’s concerns about the sustained pressures on medicines supply and the impact on community pharmacy teams. It also contains practical tips for dealing with medicine pricing and supply issues.
PSNC Briefing 023/22: How the price concession system operates
In this PSNC factsheet our Dispensing and Supply Team explain how the price concession system works (including a diagram), as well as answering some common queries.
Report product over Drug Tariff price
Complete this form to report a medicine shortage where the product can only be obtained at a price higher than the Drug Tariff listed price.